Who is sponsoring NCT04982159?

NCT04982159 is sponsored by Maimónides Biomedical Research Institute of Córdoba.

What drugs are being tested in NCT04982159?

Interventions in NCT04982159: There is no intervention. This is an observational study..

What condition does NCT04982159 study?

NCT04982159 studies Invasive Fusariosis.

Is NCT04982159 still recruiting?

NCT04982159 is currently completed. Last updated 2 June 2022.

Last reviewed 2022-06-02 · How we verify

NCT04982159

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Correlation Between Minimum Inhibitory Concentration and Clinical Outcome of Invasive Fusariosis

Completed Last updated 2 June 2022

What this trial tests

trial testing There is no intervention. This is an observational study. in Invasive Fusariosis in 11 participants. Completed in 31 December 2020.

Timeline

1 January 2020

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Maimónides Biomedical Research Institute of Córdoba
Status	Completed
Study type	OBSERVATIONAL
Enrollment	11
Start date	1 January 2020
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across Spain

Drugs / interventions tested

There is no intervention. This is an observational study.

Conditions studied

Invasive Fusariosis — all drugs for Invasive Fusariosis →

Sponsor

Maimónides Biomedical Research Institute of Córdoba

Who can join

Eligibility, any sex, with Invasive Fusariosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multi-centered, international, observational and retrospective study to analyze the correlation between MIC and clinical outcome in patients with invasive fusariosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Maimónides Biomedical Research Institute of Córdoba trials

Trials by the same sponsor.

NCT06783491 — Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Locally Ad · Phase 3 · not yet recruiting
NCT07479303 — Vitamin D Status in Young Medical Residents · completed
NCT07178379 — Hysteroscopy Anesthesia for Relief of Pain · NA · not yet recruiting
NCT06712485 — Biomarkers in EV Associated With Marrow Adiposity in Anorexia · not yet recruiting
NCT06579846 — 12-Month Efficacy of Exercise and Cytisinicline for Tobacco Abstinence · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04982159 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Maimónides Biomedical Research Institute of Córdoba
Last refreshed: 2 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04982159.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing